Actinium Pharmaceuticals Inc. Revenue 2010–2025
Actinium Pharmaceuticals Inc. annual/quarterly revenue history and growth rate from 2010 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Actinium Pharmaceuticals Inc. revenue for the quarter ending September 30, 2025 was 90000, a 100.00% increase year-over-year.
- Actinium Pharmaceuticals Inc. revenue for the twelve months ending September 30, 2025 was 1.1 M, a 0.09% decrease year-over-year.
- Actinium Pharmaceuticals Inc. annual revenue for 2025 was 90000, a 11.11% increase from 2023.
- Actinium Pharmaceuticals Inc. annual revenue for 2023 was 81000, a 92.14% decrease from 2022.
- Actinium Pharmaceuticals Inc. annual revenue for 2022 was 1.0 M, a 9.97% decrease from 2021.
- Actinium Pharmaceuticals Inc. annual revenue for 2021 was 1.1 M.
Actinium Pharmaceuticals Inc. (ATNM) — Frequently Asked Questions
Actinium Pharmaceuticals Inc. (ATNM) is a publicly traded US company. It has a market capitalization of $33M. In fiscal 2025 it reported revenue of $90,000 and net income of -$34M. Explore ATNM's stock price, financial statements, earnings history, margins and key ratios below.
What is Actinium Pharmaceuticals Inc.'s market cap?
Actinium Pharmaceuticals Inc. (ATNM) has a market capitalization of $33M.
What is the ATNM stock price?
ATNM trades at $1.05 (+3.96% on the day).
How much revenue does Actinium Pharmaceuticals Inc. make?
Actinium Pharmaceuticals Inc. reported revenue of $90,000 in fiscal 2025.
Is ATNM profitable?
In fiscal 2025, Actinium Pharmaceuticals Inc. reported net income of -$34M.